{"id":174930,"date":"2025-11-11T12:44:12","date_gmt":"2025-11-11T12:44:12","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/174930\/"},"modified":"2025-11-11T12:44:12","modified_gmt":"2025-11-11T12:44:12","slug":"13-more-drugs-vat-exempt-philstar-com","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/174930\/","title":{"rendered":"13 more drugs VAT-exempt | Philstar.com"},"content":{"rendered":"<p>                           <a href=\"https:\/\/www.philstar.com\/authors\/1685860\/rhodina-villanueva\" rel=\"nofollow noopener\" target=\"_blank\">Rhodina Villanueva<\/a> &#8211; The Philippine Star<\/p>\n<p>November 11, 2025 | 12:00am<\/p>\n<p>MANILA, Philippines \u2014 Thirteen drugs for cancer and diabetes have been added to the list of essential medicines exempted from value-added tax or VAT, according to the Food and Drug Administration (FDA).<\/p>\n<p>Cancer drugs Capivasertib (160 milligram and 200 mg film-coated tablet), irinotecan hydrochloride trihydrate (solution for intravenous infusion), irinotecan (concentrate solution for IV infusion) and Nilotinib (as hydrochloride monohydrate) have been included on the list.<\/p>\n<p>Anti-diabetic medications Gemigliptin + Dapagliflozin and Semaglutide (solutions for injection) followed.<\/p>\n<p>VAT-exempted drugs now total 2,242, the FDA said.<\/p>\n","protected":false},"excerpt":{"rendered":"Rhodina Villanueva &#8211; The Philippine Star November 11, 2025 | 12:00am MANILA, Philippines \u2014 Thirteen drugs for cancer&hellip;\n","protected":false},"author":2,"featured_media":174931,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[18,135,19,17,462,24727],"class_list":{"0":"post-174930","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-eire","9":"tag-health","10":"tag-ie","11":"tag-ireland","12":"tag-medication","13":"tag-vat"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115531131764875559","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/174930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=174930"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/174930\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/174931"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=174930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=174930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=174930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}